Labshake search
Citations for BioLegend :
1 - 50 of 369 citations for p14 ARF Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: ... while P14 T cells were stained with antibodies specific for Thy1.1 (clone OX-7, BioLegend), CD8 (clone 53-6.7 ...
-
bioRxiv - Immunology 2021Quote: ... Naive P14 Thy1.1+ Il2ra−/− cells were isolated from 4-5 week old mice by depleting CD44hi cells (Biolegend biotin anti-mouse/human CD44 ...
-
bioRxiv - Systems Biology 2019Quote: ... FcX blocking solution (BioLegend) was added in a dilution of 1:50.
-
bioRxiv - Cell Biology 2020Quote: ... FcX blocking solution (BioLegend) was added at a dilution of 1:50.
-
bioRxiv - Immunology 2021Quote: Monocyte blocking solution (BioLegend) and Brilliant Stain Buffer (BD ...
-
bioRxiv - Bioengineering 2021Quote: ... 1×106 P14 or pmel splenocytes were co-stained with Db-GP33 liposomes (10 μg/ml) and anti-mouse CD8-PE (Biolegend, Clone: 53-6.7) for 30 min on ice ...
-
bioRxiv - Immunology 2021Quote: ... Fc-blocking reagent (Biolegend, 422301) was used to block Fc receptor-introduced non-specific staining ...
-
bioRxiv - Genomics 2024Quote: ... Fc-blocking reagent (BioLegend, 422301) was used to block Fc receptor-introduced nonspecific staining ...
-
bioRxiv - Cancer Biology 2021Quote: ... blocked with FcX blocking buffer (BioLegend) for 10 minutes on ice and then incubated with hash-antibodies (TotalSeq from BioLegend ...
-
bioRxiv - Immunology 2020Quote: ... CD112 blocking antibody (clone TX31, Biolegend), 10 μM LY2109761 ...
-
bioRxiv - Immunology 2020Quote: ... CD44 blocking antibody (clone IM7, Biolegend), ILT-2 (CD85J ...
-
bioRxiv - Cancer Biology 2019Quote: ... and Fc receptor blocking solution (Biolegend), before staining with fluorochrome-conjugated anti-human antibodies specific to anti-CD3 (UCHT1)/anti-CD45 (2D1) ...
-
bioRxiv - Neuroscience 2022Quote: ... After fragment crystallizable (Fc) blocking (Biolegend), cells were stained for surface antigens (Extended Data Table 4) ...
-
bioRxiv - Immunology 2020Quote: ... CD25 blocking antibodies (Clone 3C7, BioLegend) were added to culture media prior to T cell stimulation ...
-
bioRxiv - Immunology 2023Quote: ... blocked with FcR blocking reagent (BioLegend) on ice for 10 min and then incubated with surface antibody cocktail for 30 min in dark ...
-
bioRxiv - Immunology 2023Quote: ... underwent blocking in TruStainFcX (Biolegend, 422302) for 10 min and were stained with a mixture of EPCAM (anti-CD326 PE ...
-
bioRxiv - Immunology 2023Quote: ... After Fc blocking (TruStain FcX; BioLegend), cells were stained with a metal-conjugated surface antibody cocktail (Table 2) ...
-
bioRxiv - Cancer Biology 2023Quote: ... performed with Fc blocking (422302, BioLegend), and labelled with anti-CD138 (142508 ...
-
bioRxiv - Immunology 2023Quote: ... DQ blocking antibody (Biolegend, Cat# 361702) were included to confirm MHC dependent IFNγ release.
-
bioRxiv - Immunology 2021Quote: ... 20 µL diluted peptide and 20µL 1µg/mL UV-sensitive peptide HLA-A2 monomer (BioLegend) were added into 96-well plates and mixed well by pipetting up and down ...
-
bioRxiv - Immunology 2021Quote: ... VEGFA blocking antibody (BioLegend, 2G11-2A05, 50μg) was administered intravenous ...
-
bioRxiv - Immunology 2020Quote: ... Fc receptor blocking antibody (CD16/CD32; Biolegend), anti-EpCAM (clone G8.8 ...
-
bioRxiv - Immunology 2022Quote: ... Fc receptor-blocking antibody (CD16/CD32; BioLegend), anti-EpCAM (clone G8.8 ...
-
bioRxiv - Immunology 2020Quote: ... Pre-blocking step with TruStain FcX (BioLegend) was included for all staining ...
-
bioRxiv - Immunology 2022Quote: ... 10 µl TruStain FcX blocking reagent (BioLegend) was added ...
-
bioRxiv - Immunology 2022Quote: After Fc-blocking using FcX reagents (BioLegend), cells were incubated with primary antibodies in FACS buffer for 30 min at 4°C and if necessary ...
-
bioRxiv - Genomics 2022Quote: ... FcX blocking solution (BioLegend catalogue no. 101319) was added at a dilution of 1:50 ...
-
bioRxiv - Systems Biology 2022Quote: ... Human TruStain FcX FC blocking reagent (BioLegend) was added according to manufacturers’ instructions for 10min on ice ...
-
bioRxiv - Immunology 2023Quote: ... blocking antibodies to TNFa (MAb-1, Biolegend) were added at a concentration of 1 ug/mL ...
-
bioRxiv - Immunology 2023Quote: ... HLA-ABC blocking antibody (Biolegend, Cat# 311428) and HLA-DR ...
-
bioRxiv - Immunology 2024Quote: ... Human TrueStain FcX blocking solution (Biolegend, 422302) was added to cells for 10 min before staining ...
-
bioRxiv - Immunology 2024Quote: ... PD-1 blocking antibody (29F.1A12, Biolegend) was freshly added (10μg/ml ...
-
bioRxiv - Immunology 2022Quote: ... Cells were washed three times in ice cold blocking buffer and re-suspended in blocking buffer containing 0.1 μg/ml DAPI (Biolegend, USA).
-
bioRxiv - Cancer Biology 2023Quote: ... 100 000-200 000 cells per sample were processed by blocking with 5 µl of Human TruStain FcX Blocking Solution (BioLegend) for 10 min at 4°C ...
-
bioRxiv - Developmental Biology 2021Quote: ... 0.25ug of TruStain FcX™ Blocking reagent (Biolegend) was added for 10 minutes on ice ...
-
bioRxiv - Genomics 2020Quote: ... and 5 μL TruStain FcX blocking antibodies (Biolegend) were added and incubated for 10 minutes on ice ...
-
bioRxiv - Immunology 2020Quote: ... HLA-ABC blocking antibody (clone W6/32, Biolegend), CD44 blocking antibody (clone IM7 ...
-
bioRxiv - Immunology 2020Quote: ... 2 μl of Trustain FcR blocking reagent (BioLegend), 3 μl of anti-human CD45 antibody (clone HI100 ...
-
bioRxiv - Cancer Biology 2019Quote: ... or PD-1 blocking Ab (clone EH12.2H7, BioLegend) were added to the media and incubated at 37 °C for 72 hrs ...
-
bioRxiv - Microbiology 2020Quote: ... Following blocking with FcγR antibody (BioLegend, clone 93), cells were stained on ice with CD45 BUV395 (BD BioSciences clone 30-F11) ...
-
bioRxiv - Cancer Biology 2021Quote: ... after incubation with an Fc blocking antibody (Biolegend). Finally ...
-
bioRxiv - Immunology 2023Quote: ... Human TruStain FcX (Fc receptor blocking solution, BioLegend) was used to avoid nonspecific binding ...
-
bioRxiv - Immunology 2023Quote: ... blocking or anti-TNFR2 monoclonal antibody (358408, Biolegend) or its isotype control (400544 ...
-
bioRxiv - Bioengineering 2023Quote: ... followed by blocking with Trustain FcX solution (Biolegend) and staining with anti-human CD33 antibody conjugated to Brilliant Violet 605 (BV605 ...
-
bioRxiv - Immunology 2023Quote: ... After blocking with anti-CD16/CD32 (2.4G2, BioLegend), cells were stained for cell surface molecules on ice for 20 min ...
-
bioRxiv - Immunology 2024Quote: ... ICAM-1 blocking antibody (clone YN1/1.7.4, Biolegend), CD18-activating antibody (clone M18/2 ...
-
bioRxiv - Immunology 2023Quote: ... followed by blocking with TruStain FCX PLUS (Biolegend), and then staining of surface markers in Brilliant stain buffer (BD Biosciences) ...
-
bioRxiv - Immunology 2022Quote: ... Blocking and antibody solutions were further supplemented with 1:150 Human TruStain FcX™ Fc Receptor Blocking Solution (BioLegend, London, UK), to reduce non-specific binding ...
-
bioRxiv - Immunology 2024Quote: ... or gE overlapping peptides (10 μg/mL, 153 peptides, 15mers with 11 aa overlap) in the presence of brefeldin A (BFA, Biolegend) for 8 hours or 16 hours at 37 °C ...
-
bioRxiv - Immunology 2022Quote: ... PBMCs were treated with FcX blocking antibodies (BioLegend, #4422302) to reduce non-specific labeling of the cells ...